tofisopam has been researched along with Disease Models, Animal in 2 studies
tofisopam: structure; dextofisopam is the R-enantiomer of tofisopam & antidiarrheal
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we investigated the potential therapeutic effects of tofisopam, a 2,3-benzodiazepine derivative anxiolytic, on cognitive deficits in rats with scopolamine-induced amnesia." | 3.96 | Antiamnesic effects of tofisopam against scopolamine-induced cognitive impairments in rats. ( Can, ÖD; Demir Özkay, Ü; Üçel, Uİ; Ulupinar, E, 2020) |
| "Tofisopam is a member of the 2,3-benzodiazepine compound family which is marketed for the treatment of anxiety in some European countries." | 1.36 | The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. ( Rundfeldt, C; Socała, K; Wlaź, P, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Üçel, Uİ | 1 |
| Can, ÖD | 1 |
| Demir Özkay, Ü | 1 |
| Ulupinar, E | 1 |
| Rundfeldt, C | 1 |
| Socała, K | 1 |
| Wlaź, P | 1 |
2 other studies available for tofisopam and Disease Models, Animal
| Article | Year |
|---|---|
Antiamnesic effects of tofisopam against scopolamine-induced cognitive impairments in rats.
Topics: Amnesia; Animals; Avoidance Learning; Benzodiazepines; Cell Plasticity; Cell Proliferation; Cognitiv | 2020 |
The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis.
Topics: Animals; Antidepressive Agents; Benzodiazepines; Disease Models, Animal; Isoenzymes; Male; Mice; Pho | 2010 |